<?xml version="1.0" encoding="UTF-8"?>
<p id="par0330">Taking together, it is increasingly clear that the specific inhibition of CCR5 expression through different techniques is gaining pace in different clinical contexts. The pharmacological CCR5 blockade has many benefits in different clinical situations, particularly in the treatment of HIV infection. Also, the potential of gene editing (especially in somatic cells) for the treatment of genetic diseases is very promising. However, considering viral infections, two aspects must be considered, as follows:</p>
